Individual Disclosures for the NCCN Survivorship Panel.
| Panel Member | Clinical Research Support |
Advisory Boards, Speakers Bureau, Expert Witness, or Consultant |
Patent, Equity, or Royalty |
Other | Date Completed |
|---|---|---|---|---|---|
| Madhuri Are, MD | None | None | None | None | 5/15/13 |
| K. Scott Baker, MD, MS | None | None | None | None | 11/22/13 |
| Robert W. Carlson, MD | None | None | None | None | 12/9/13 |
| Elizabeth Davis, MD | None | None | None | None | 3/13/12 |
| Crystal S. Denlinger, MD | ImClone Systems Incorporated; MedImmune Inc.; and Merrimack Pharmaceuticals |
None | None | None | 6/21/13 |
| Stephen B. Edge, MD | None | None | None | None | 6/5/12 |
| Debra L. Friedman, MD, MS |
None | None | None | None | 5/26/13 |
| Mindy Goldman, MD | Pending | ||||
| Lee Jones, PhD | None | None | None | None | 2/2/12 |
| Allison King, MD | None | None | None | None | 8/12/13 |
| Elizabeth Kvale, MD | None | None | None | None | 10/7/13 |
| Terry S. Langbaum, MAS | None | None | None | None | 8/13/13 |
| Jennifer A. Ligibel, MD | None | None | None | None | 10/3/13 |
| Mary S. McCabe, RN, BS, MA |
None | None | None | None | 8/12/13 |
| Kevin T. McVary, MD | Allergan, Inc.; Eli Lilly and Company; NeoTract, Inc.; and National Institute for Diabetes and Digestive and Kidney Diseases |
Allergan, Inc.; GlaxoSmithKline; Eli Lilly and Company; and Watson Pharmaceuticals Inc. |
None | None | 6/7/13 |
| Michelle Melisko, MD | Celldex Therapeutics; and Galena Biopharma |
Agendia BV; Genentech, Inc.; and Novartis Pharmaceuticals Corporation |
None | None | 10/11/13 |
| Jose G. Montoya, MD | None | None | None | None | 12/6/13 |
| Kathi Mooney, RN, PhD | University of Utah | None | None | None | 9/30/13 |
| Mary Ann Morgan, PhD, FNP-BC |
None | None | None | None | 8/19/13 |
| Tracey O’Connor, MD | None | None | None | None | 6/13/13 |
| Electra D. Paskett, PhD | Merck & Co., Inc. | None | None | None | 6/13/13 |
| Muhammad Raza, MD | None | None | None | None | 8/23/12 |
| Karen L. Syrjala, PhD | None | None | None | None | 10/3/13 |
| Susan G. Urba, MD | None | Eisai Inc.; and Helsinn Therapeutics (U.S.), Inc. |
None | None | 10/9/13 |
| Mark T. Wakabayashi, MD, MPH |
None | None | None | None | 6/19/13 |
| Phyllis Zee, MD | Philips/Respironics | Merck & Co., Inc.; Sanofi-Aventis Japan; UCB, Inc.; and Purdue Pharma L.P. |
None | None | 4/5/12 |
The NCCN Guidelines Staff have no conflicts to disclose.